No results for ‘’
Concord Biotech Ltd
₹1051.20
(4.40%)
Mon, 01 Jun 2026, 07:00 pm
Commercial Services
Miscellaneous Commercial Services
24.5KConcord Biotech Enterprise Value (EV)
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 51.68 | 47.19 |
| Price to book ratio | 0 | 0 | 0 | 0 | 10.43 | 9.67 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 15.95 | 14.86 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 59.54 | 70.88 |
| Enterprise value | 0 | 0 | 0 | 0 | 156.41B | 172.23B |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 37.31 | 34.74 |
| Debt to equity ratio | 0.07 | 0.09 | 0.06 | 0.02 | 0.01 | 0 |
| Return on equity % | 0 | 26.55 | 16.64 | 20.06 | 21.88 | 22.26 |
Concord Biotech Ltd Enterprise Value
The Concord Biotech Ltd Enterprise Value is a key financial metric used by investors to evaluate Concord Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Concord Biotech Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Concord Biotech Ltd (NSE: CONCORDBIO, BSE: 543960) is currently trading at ₹1051.20, with a market capitalization of ₹109.73B. As a leading company in the Commercial services sector and Miscellaneous commercial services industry, monitoring the Concord Biotech Ltd Enterprise Value is essential for fundamental analysis.
Concord Biotech Ltd Enterprise Value Current Value
The current Concord Biotech Ltd Enterprise Value stands at 172.23B.
The latest Concord Biotech Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Concord Biotech Ltd Enterprise Value Historical Trend
The Concord Biotech Ltd Enterprise Value has shown the following historical trend:
- 2024: 172.23B
- 2023: 156.41B
- 2022: 0
- 2021: 0
- 2020: 0
The recent rise in Concord Biotech Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Concord Biotech Ltd Enterprise Value Indicates for Investors
The Concord Biotech Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Concord Biotech Ltd.
Concord Biotech Ltd Enterprise Value Analysis Summary
The Concord Biotech Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Concord Biotech Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Concord Biotech Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.